STOCK TITAN

HCWC (HCWC) director gains 12,500 vested shares plus large unvested stock grants

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

HEALTHY CHOICE WELLNESS CORP. director Gary Bodzin reported acquiring 12,500 shares of Class A Common Stock through a restricted stock award that vested on May 25, 2026. After this vesting, he holds 62,500 shares directly. Footnotes state he also has 150,000 and 87,500 unvested restricted shares from earlier time-based awards that vest in equal quarterly installments, with next vesting dates in August 2026, and that these restricted shares fully vest upon certain change of control events.

Positive

  • None.

Negative

  • None.
Insider Bodzin Gary
Role null
Type Security Shares Price Value
Grant/Award Class A Common Stock 12,500 $0.00 --
Holdings After Transaction: Class A Common Stock — 62,500 shares (Direct, null)
Footnotes (1)
  1. Restricted stock award of 12,500 shares vested on May 25, 2026. Registrant's holdings include (a) 62,500 shares of common stock held directly, (b) 150,000 unvested shares of restricted common stock granted on November 12, 2025, which is a time-based restricted stock award that vests in eight equal quarterly installments of 25,000 shares with next vesting on August 12, 2026, and (c) 87,500 unvested shares of restricted common stock granted on February 25, 2026, which is a time-based restricted stock award that vests in eight equal quarterly installments of 12,500 shares with next vesting occurring on August 25, 2026. The Restricted Stock will immediately vest upon the occurrence of certain change of control events set forth in the Reporting Person's Restricted Stock Award Agreements.
Vested restricted shares 12,500 shares Restricted stock award vested on May 25, 2026
Direct holdings after transaction 62,500 shares Class A Common Stock held directly after vesting
Unvested restricted shares (Nov 2025 grant) 150,000 shares Time-based restricted stock granted November 12, 2025
Unvested restricted shares (Feb 2026 grant) 87,500 shares Time-based restricted stock granted February 25, 2026
Quarterly vesting tranche (150,000 grant) 25,000 shares Vests in eight equal quarterly installments, next on August 12, 2026
Quarterly vesting tranche (87,500 grant) 12,500 shares Vests in eight equal quarterly installments, next on August 25, 2026
Transaction price per share $0.0000 per share Equity grant/award, not an open-market purchase
restricted stock award financial
"Restricted stock award of 12,500 shares vested on May 25, 2026."
A restricted stock award is company shares given to an employee or executive that cannot be sold or fully owned until certain conditions—like staying with the company for a set time or hitting performance targets—are met. Think of it as a gift that only becomes yours after you fulfill specific obligations; for investors, these awards matter because they can increase the total shares outstanding when they vest, reveal how management is being paid and motivated, and create potential selling pressure when restrictions lift.
time-based restricted stock award financial
"which is a time-based restricted stock award that vests in eight equal quarterly installments"
change of control events financial
"The Restricted Stock will immediately vest upon the occurrence of certain change of control events"
Class A Common Stock financial
"security_title: Class A Common Stock"
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Bodzin Gary

(Last)(First)(Middle)
3800 NORTH 28TH WAY, UNIT 1

(Street)
HOLLYWOOD FLORIDA 33020

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
HEALTHY CHOICE WELLNESS CORP. [ HCWC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/26/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class A Common Stock05/25/2026A(1)12,500A$0.0062,500(2)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Restricted stock award of 12,500 shares vested on May 25, 2026.
2. Registrant's holdings include (a) 62,500 shares of common stock held directly, (b) 150,000 unvested shares of restricted common stock granted on November 12, 2025, which is a time-based restricted stock award that vests in eight equal quarterly installments of 25,000 shares with next vesting on August 12, 2026, and (c) 87,500 unvested shares of restricted common stock granted on February 25, 2026, which is a time-based restricted stock award that vests in eight equal quarterly installments of 12,500 shares with next vesting occurring on August 25, 2026. The Restricted Stock will immediately vest upon the occurrence of certain change of control events set forth in the Reporting Person's Restricted Stock Award Agreements.
/s/ Martin Schrier, as Attorney-in-Fact for Gary A. Bodzin05/27/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did HCWC director Gary Bodzin report?

Director Gary Bodzin reported acquiring 12,500 HCWC Class A Common shares through a restricted stock award vesting on May 25, 2026. The shares were granted at no cash cost as equity compensation, not purchased in the open market.

How many HCWC shares does Gary Bodzin hold after this Form 4?

After this vesting, Gary Bodzin holds 62,500 HCWC common shares directly. Footnotes also describe additional unvested restricted stock awards that, once vested, would increase his total equity exposure to the company over time.

What restricted stock awards does HCWC’s Gary Bodzin have outstanding?

Gary Bodzin has 150,000 unvested restricted HCWC shares from a November 12, 2025 grant and 87,500 unvested shares from a February 25, 2026 grant. Both are time-based awards vesting in eight equal quarterly installments.

When do Gary Bodzin’s HCWC restricted stock awards vest?

One 150,000-share award vests in eight quarterly installments of 25,000 shares, next on August 12, 2026. Another 87,500-share award vests in eight installments of 12,500 shares, next on August 25, 2026, subject to continued conditions.

What happens to HCWC restricted stock if a change of control occurs?

The filing states Bodzin’s restricted HCWC shares will immediately vest upon certain change of control events listed in his Restricted Stock Award Agreements. This means qualifying transactions could accelerate vesting, increasing his fully vested shareholdings more quickly.